行业研究报告题录
制造业--医药制造业(2019年第33期)
(报告加工时间:2019-09-16 -- 2019-10-07)

行业资讯

境内分析报告

  • 行业月度报告-医药201907
    供给:7 月,医药行业生产动能继续上升。7 月,医药行业工业增加值为 7.4%,增速较 6 月提高 1.5 个百分点。1~7 月,医药行业工业增加值为 6.7%,增速较 1~6 月提高 0.1 个百分点。需求:7 月,药品零售市场需求平稳,中西药品零售总额保持稳定增长。1~7 月,中西药品零售总额为 3423.6 亿元,同比增长 11%,增速较1~6 月提高 0.1 个百分点。7 月,中西药品零售总额为 485 亿元,同比增长 11.6%,环比下降 5.2%。

境外分析报告

  • 越南月经杯市场报告(2019-2026年)
    A menstrual cup is a feminine hygiene product that is used during menstruation. It is inserted into the vagina and one can keep it inside for a maximum duration of 12 hours. Its purpose is to prevent menstrual blood from leaking onto the clothes. It is made up of either latex, silicone, or thermoplastic elastomer. Silicon and thermoplastic elastomer are hypoallergic, which means that the wearer can be safe from unwanted irritation and allergies. The menstrual cups are available in a smaller and a larger size, where smaller size is recommended for women under 30 (who have not given birth vaginally) and the larger size is recommended for women who are over 30 (have given birth vaginally or have a heavy flow). The report includes market study on disposable and reusable menstrual cups and does not include other menstrual care products such as sanitary napkins and tampons.
  • 加拿大糖尿病护理药物和设备市场-增长,趋势和预测(2019-2024年)
    Geographically, the market scope covers Canada, for which the market size and forecast value are provided separately. The market size provided in the report has been derived from the revenue generated by products. For estimating the market size of the product, the average selling price (ASP) of a product in the region was multiplied with the sales volume (new sales and replacement rate, based on applicability). While each drug is unique in the way it works in helping patients with diabetes, to keep their condition under control, certain drugs have similar actions and are, thus, grouped in the same class of drugs. The way in which they are administered can also differ, with some medicines taken orally and others injected directly into the blood (insulin and GLP-1).
  • 全球脊柱外科手术设备市场-按类型细分-增长,趋势和预测(2019-2024年)
    Spine surgery is one of the fast-growing surgical techniques. It has evolved into one of the major segments of the orthopedic industry. Spinal surgery is traditionally performed as open surgery, wherein a long incision allows a surgeon to access the spinal anatomy of a body.  However, owing to the recent technological advances, the number of minimally invasive procedures has increased significantly, thereby, the report covers minimally invasive procedures, along with the traditional open surgery techniques. The market estimates provided in this report have been derived as a product of average selling price (ASP) and the volume sold in a year.
  • 美国医疗保健BPO市场-增长,趋势和预测(2019-2024年)
    As per the scope of this report, the healthcare BPO (business process outsourcing) refers to a process, in which the healthcare providers select the most suited third- party vendor for specific business processes. Offshore medical care is a swiftly growing in the United States. Americans spend more on health care than do people in any other nation. Healthcare outsourcing allows the hospitals and medical professionals to save their energy and valuable time on patient care.
  • 全球病毒过滤市场-增长,趋势和预测(2019-2024年)
    Virus filtration is an important operation in the biopharmaceutical industry, as it ensures that the products are adequately purified to be fit for consumption. Virus filtration also helps to optimize process economics and prevents the loss of valuable products. The definitions for the individual segments have been provided in the respective segments. The market estimates provided are entirely based on the segments tracked in this report. The estimates provided in this report may not be in line with other reports, if the segments tracked in those reports are not in line with this report.
  • 全球金枪鱼和藻类Omega-3成分市场-增长,趋势和预测(2019-2024年)
    The global tuna and algae omega-3 ingredients market report offers key insights into the latest developments.It analyzes the recent trends, drivers, and challenges affecting the market space for tuna and algae omega-3 ingredients. It covers the various types of tuna and algae omega-3 ingredients, along with their corresponding shares, in the market. By type, the algae omega-3 ingredients market is segmented by type into EPA, DHA, and EPA/DHA. On the basis of concentration, the algae omega-3 ingredients market has been segmented into high, medium and low co ncentratio n. Tuna omega-3 ingredients is segmented in to crude and refined tuna oil.
  • 澳大利亚伤口护理管理设备市场-增长,趋势和预测(2019-2024年)
    Wound management products are used by healthcare professionals as well as patients to support wound healing process. These products are used for minor as well as to treat serious wounds, such as chronic and complex wounds, like diabetic ulcers. Growth in the Australian wound management market is mainly driven by the demand for effective products to heal refractory wounds.

投资分析报告

  • 医药行业:集采扩围超预期,量价差异引深思-点评报告
    9 月24 日,参加扩围的25 个省份及新疆生产建设兵团在上海开展联合招采, 产生了拟中选结果,25 个“4+7”试点药品扩围采购全部成功,价格均不高 于“4+7”试点中选价格,拟中选结果公示后正式发布。本次联盟采购共有 77 家企业,产生拟中选企业45 家,拟中选产品60 个,与联盟地区2018 年 最低采购价相比,拟中选价平均降幅59%,与“4+7”试点中选价格水平相 比,平均降幅25%。
  • 证券研究报告_医药行业:三因素共振,提升本土器械企业竞争力-科技产业自主可控之医疗器械
    MAH制度:符合条件的医疗器械注册申请人可以单独申请产品注册证,并委托给有资质和生产能力的企业生产。2017年开始上海试点,2018年拓展至广东、天津、福建,2019年拓展至21省市。有助于鼓励器械创新、加快器械上市、优化资源配置。
  • 医药行业:立足业绩,把握长期发展逻辑-2019年4季度投资策略报告
    年初至今(2019 年1 月1 日至2019 年9 月4 日),申万医药生物板块上涨30.50%,沪深300 指数上涨29.08%,医药板块整体跑赢沪深300 指数1.42个百分点,涨跌幅在申万28 个一级行业中排名第8 位。从总体医药指数走势看,1 月份医药指数受集采和辅助性用药等政策的影响下跌2.54%,同期沪深300 上涨6.34%,医药板块涨幅大幅落后其他板块;随后,2 月份至4 月中旬,全市场快速上涨,2 月1 日到4 月10 日,医药板块上涨43.35%;4月10 日之后,医药指数在区间内上下震荡,至今下跌4.97%。总体来说,经过了去年中美贸易摩擦等多因素的过度恐慌,A 股今年正逐步回归理性。医药板块受去年带量采购等一系列政策的影响,整个板块不断下行,但是随着市场对政策的逐步消化、中美贸易摩擦不断的反复以及许多龙头公司都交出了漂亮的财报等多因素影响,医药板块逐步开始发力,今年整体走势位于申万28 个一级行业的第8 位。
  • 医药生物行业:集采扩面招标落地,仿制药竞争格局重塑
    9 月24 日,国家组织药品集中采购和使用试点全国扩围产生 拟中选结果,25 个“4+7”试点药品扩围采购全部成功,价格都降 低到不高于“4+7”试点中选价格的水平,本次联盟采购共有77 家 企业。产生拟中选企业45 家,拟中选产品60 个。与联盟地区2018 年最低采购价相比,拟中选价平均降幅59%;与“4+7”试点中选 价格水平相比,平均降幅25%。
  • 医药生物行业:仿制药全面步入低价、寡头时代-《国家药品集采全国扩围拟中选结果》点评
    9 月25 日联采办公告《国家药品集采全国扩围拟中选结果》,45 家企业进入扩围,60 个产品拟中选,与“4+7”中价相比,平均降幅25%。我们认为,本次扩围降价幅度符合市场预期,尽管第一轮4+7 降价与扩围降价具有示范效应,但基于全国供应压力,监管层已明确适度竞价,未来集采的降价幅度有望缓和,但拥挤/大规模品种降价仍不容乐观。建议关注边际改善与长期玩家两条主线,如石药集团、科伦药业、华海药业、乐普医疗等。
  • 医药健康行业:微芯生物1类新药西格列他上市申请获受理
    本周VA市场报价348-360元/公斤。新和成厂家提价至550 元/公斤,需求不佳抑制市场,随着库存的消耗,本周市场询问 有所增加。本周D3市场报价170-190元/公斤左右,有新厂家产 品进入,市场报价回调。本周B1市场报价在185-195元/公斤左 右。天新药业计划7月20日起停产检修60天。本周泛酸钙市场 报价330-360元/公斤左右,新进入厂家产量低,近日市场成交 有所好转。本周(MSB)K3市场报价95-105元/公斤,因原料成 本上涨,环保压力大,厂家持挺价心态,国内需求不佳,近日 K3市场整理。本周VC市场报价23-26元/公斤左右,VC市场底部 抬升。
  • 医药生物行业:2019CSCO有何亮点?硬核资产紧握一线挑二线!继续推荐2_X
    发改委、卫健委等四部委:《关于支持建设博鳌乐城国际医疗旅游先行区的实施方案》;国家药监局:《药品监管系统现有证明事项拟保留目录(征求意见稿)》;山东省公共资源交易中心:《关于开展山东省药品集中采购挂网产品价格联动的通知》。
  • 医疗保健行业:带量采购扩面开标,集采进入常态化-药品集中带量采购扩面点评
    9 月24 日,扩面拟中选结果流出。根据目前流出的报价情况来看,拟中选平均降幅达超过22%(官方数据平均降幅在25%),主要系竞争格局好的品种价格未有较大幅度调整。国产竞争企业≤3 的品种中,降幅在一般在0-3%左右,但好格局品种部分企业主动降价帕罗西汀-华海继续降价36%,吉非替尼-齐鲁降价53%,伊马替尼-正大天晴降价14%。国产竞争品类≥3,竞争相对惨烈,平均降幅达到42%。
  • 医药生物行业:行业景气度有望提升,头部企业优势进一步凸显-血制品行业报告
    血液制品(Blood Products)简称血制品,在广义上包括血源和重组的血浆蛋白制品,在狭义上仅包含血源的蛋白质。常见的血制品主要包括白蛋白、免疫球蛋白和凝血因子三类。血浆是提取血制品的原材料:血浆是人体血液的重要组成部分,分离提纯血浆可以得到白蛋白、免疫球蛋白及凝血因子三大类血液制品。人体血液主要成分包括血浆(~50%)、红细胞(~42%)及白细胞和血小板(~8%)。血浆中含有7%的蛋白质,包括白蛋白(60%)、免疫球蛋白(15%)、凝血因子(<1%)和其他蛋白质成分(24%)。
  • 医药行业:美迪西成功过会,神州细胞IPO获受理-科创板生物医药公司系列研究第22期
    本周科创板上市生物医药企业股价普跌,心脉医疗、南微医学和微芯生物分别下 跌1.44%、2.43%和5.33%。目前登陆科创板的微芯生物、南微医学和心脉医疗3 家企业均具有稀缺性且企业竞争优势突出,我们认为科创板作为鼓励创新药械的 融资平台,创新性、稀缺性成为奠定市值基础,建议把握相关公司创新产品研发 持续迭代过程中投资机会。

如果没有您需要的报告,您可以到行业研究报告数据库(http://hybg.hbsts.org.cn )查找或定制

如果您在使用中有任何问题,请及时反馈给我们。